AUPH in the 13F filings
Aurinia Pharmaceuticals Inc · CUSIP 05156V102
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 3 listed it in both
- Shares listed
- 18,251,999
- combined, among listed positions
- Reported value
- $271m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 16 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +944,998.
Managers listing AUPH in Q1 2026
27 of 27 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Investments LPexisting position · 3,428,705 shares now+1,465,963
- AQR Capital Management LLCexisting position · 948,810 shares now+467,474
- Marshall Wace LLPexisting position · 1,874,597 shares now+299,640
- Walleye Capital LLCexisting position · 321,567 shares now+298,662
- Man Group PLCexisting position · 951,412 shares now+98,741
Reductions
- Millennium Management LLCexisting position · 117,169 shares now-621,137
- Citadel Advisors LLCexisting position · 274,574 shares now-504,921
- Jane Street Group LLCexisting position · 452,104 shares now-458,633
- Voloridge Investment Management LLCexisting position · 528,172 shares now-211,272
- Squarepoint Ops LLCexisting position · 319,804 shares now-124,223
New positions and exits
New (0)
No new position among listed positions.
Exited (2)
- Schonfeld Strategic Advisors LLCwas $618k
- Verition Fund Management LLCwas $468k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2017 | 1 | $1.8m | n.a. | n.a. |
| Q2 2017 | 1 | $2.1m | n.a. | n.a. |
| Q3 2017 | 1 | $2.4m | n.a. | n.a. |
| Q4 2017 | 1 | $2.0m | n.a. | n.a. |
| Q1 2018 | 1 | $1.6m | n.a. | n.a. |
| Q3 2018 | 1 | $2.3m | n.a. | n.a. |
| Q1 2019 | 1 | $2.7m | n.a. | n.a. |
| Q2 2019 | 1 | $3.9m | n.a. | n.a. |
| Q3 2019 | 1 | $2.1m | n.a. | n.a. |
| Q4 2019 | 6 | $128m | n.a. | n.a. |
| Q1 2020 | 3 | $75m | n.a. | n.a. |
| Q2 2020 | 3 | $70m | n.a. | n.a. |
| Q3 2020 | 3 | $57m | n.a. | n.a. |
| Q4 2020 | 2 | $39m | n.a. | n.a. |
| Q1 2021 | 1 | $10m | n.a. | n.a. |
| Q2 2021 | 1 | $8.2m | n.a. | n.a. |
| Q3 2021 | 2 | $19m | n.a. | n.a. |
| Q4 2021 | 2 | $24m | n.a. | n.a. |
| Q1 2022 | 1 | $866k | n.a. | n.a. |
| Q2 2022 | 1 | $1.7m | n.a. | n.a. |
| Q3 2022 | 1 | $2.2m | n.a. | n.a. |
| Q4 2022 | 1 | $5.3m | n.a. | n.a. |
| Q1 2023 | 3 | $34m | n.a. | n.a. |
| Q2 2023 | 1 | $4.8m | n.a. | n.a. |
| Q3 2023 | 1 | $3.9m | n.a. | n.a. |
| Q4 2023 | 1 | $5.8m | 1 | 0 |
| Q1 2024 | 1 | $2.5m | 0 | 1 |
| Q2 2024 | 2 | $4.5m | 2 | 0 |
| Q3 2024 | 2 | $5.9m | 1 | 1 |
| Q4 2024 | 2 | $10m | 1 | 0 |
| Q1 2025 | 1 | $2.5m | 1 | 0 |
| Q2 2025 | 1 | $2.8m | 1 | 0 |
| Q3 2025 | 1 | $2.9m | 0 | 1 |
| Q4 2025 | 4 | $104m | 22 | 8 |
| Q1 2026 | 3 | $54m | 16 | 10 |
| Q2 2026 | 2 | $63m | 14 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AUPH and LLY →AUPH and JNJ →AUPH and VRTX →Choose a stock to compare with AUPH →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AUPH, latest filings →Back to the 13F Explorer →